BEAM vs LNC · rev $63.5M vs P/E 4.9, $5.94B cap
Beam Therapeutics Inc (BEAM) versus Lincoln National Corporation (LNC) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
LNC does not have a complete income-statement cache yet.
BEAM currently screens at market cap $2.01B. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
Not investment advice. Open the BEAM and LNC stock pages for the full models.
Not investment advice.